% alzhub.org library filter
% Source: https://alzhub.org/research?author=Scheltens+P&atag=cerebrospinal
% 18 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{verberk2021-36098162,
  author  = {Verberk, I. M. W. and Laarhuis, M. B. and van den Bosch, K. A. and Ebenau, J. L. and van Leeuwenstijn, M. and Prins, N. D. and Scheltens, P. and Teunissen, C. E. and others},
  title   = {{Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study}},
  journal = {The lancet. Healthy longevity},
  year    = {2021},
  doi     = {10.1016/s2666-7568(20)30061-1},
  pmid    = {36098162},
  url     = {https://doi.org/10.1016/s2666-7568(20)30061-1}
}

@article{visser2009-19523877,
  author  = {Visser, P. J. and Verhey, F. and Knol, D. L. and Scheltens, P. and Wahlund, L. O. and Freund-Levi, Y. and Tsolaki, M. and Minthon, L. and others},
  title   = {{Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study}},
  journal = {The Lancet. Neurology},
  year    = {2009},
  doi     = {10.1016/s1474-4422(09)70139-5},
  pmid    = {19523877},
  url     = {https://doi.org/10.1016/s1474-4422(09)70139-5}
}

@article{kester2015-26366630,
  author  = {Kester, M. I. and Teunissen, C. E. and Crimmins, D. L. and Herries, E. M. and Ladenson, J. H. and Scheltens, P. and van der Flier, W. M. and Morris, J. C. and others},
  title   = {{Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.1867},
  pmid    = {26366630},
  url     = {https://doi.org/10.1001/jamaneurol.2015.1867}
}

@article{vanmaurik2017-29049480,
  author  = {van Maurik, I. S. and Zwan, M. D. and Tijms, B. M. and Bouwman, F. H. and Teunissen, C. E. and Scheltens, P. and Wattjes, M. P. and Barkhof, F. and others},
  title   = {{Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project}},
  journal = {JAMA neurology},
  year    = {2017},
  doi     = {10.1001/jamaneurol.2017.2712},
  pmid    = {29049480},
  url     = {https://doi.org/10.1001/jamaneurol.2017.2712}
}

@article{babapourmofrad2020-32788242,
  author  = {Babapour Mofrad, R. and Tijms, B. M. and Scheltens, P. and Barkhof, F. and van der Flier, W. M. and Sikkes, S. A. M. and Teunissen, C. E.},
  title   = {{Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000010629},
  pmid    = {32788242},
  url     = {https://doi.org/10.1212/wnl.0000000000010629}
}

@article{kester2015-26383836,
  author  = {Kester, M. I. and Teunissen, C. E. and Sutphen, C. and Herries, E. M. and Ladenson, J. H. and Xiong, C. and Scheltens, P. and van der Flier, W. M. and others},
  title   = {{Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0142-1},
  pmid    = {26383836},
  url     = {https://doi.org/10.1186/s13195-015-0142-1}
}

@article{kester2014-24818585,
  author  = {Kester, M. I. and Goos, J. D. and Teunissen, C. E. and Benedictus, M. R. and Bouwman, F. H. and Wattjes, M. P. and Barkhof, F. and Scheltens, P. and others},
  title   = {{Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers}},
  journal = {JAMA neurology},
  year    = {2014},
  doi     = {10.1001/jamaneurol.2014.754},
  pmid    = {24818585},
  url     = {https://doi.org/10.1001/jamaneurol.2014.754}
}

@article{mulder2010-19833838,
  author  = {Mulder, C. and Verwey, N. A. and van der Flier, W. M. and Bouwman, F. H. and Kok, A. and van Elk, E. J. and Scheltens, P. and Blankenstein, M. A.},
  title   = {{Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease}},
  journal = {Clinical chemistry},
  year    = {2010},
  doi     = {10.1373/clinchem.2009.130518},
  pmid    = {19833838},
  url     = {https://doi.org/10.1373/clinchem.2009.130518}
}

@article{ramakers2013-22954311,
  author  = {Ramakers, I. H. and Verhey, F. R. and Scheltens, P. and Hampel, H. and Soininen, H. and Aalten, P. and Rikkert, M. O. and Verbeek, M. M. and others},
  title   = {{Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment}},
  journal = {Psychological medicine},
  year    = {2013},
  doi     = {10.1017/s0033291712001870},
  pmid    = {22954311},
  url     = {https://doi.org/10.1017/s0033291712001870}
}

@article{vanharten2013-23232269,
  author  = {van Harten, A. C. and Visser, P. J. and Pijnenburg, Y. A. and Teunissen, C. E. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.},
  title   = {{Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.08.004},
  pmid    = {23232269},
  url     = {https://doi.org/10.1016/j.jalz.2012.08.004}
}

@article{kester2009-19858456,
  author  = {Kester, M. I. and van der Vlies, A. E. and Blankenstein, M. A. and Pijnenburg, Y. A. and van Elk, E. J. and Scheltens, P. and van der Flier, W. M.},
  title   = {{CSF biomarkers predict rate of cognitive decline in Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181bd8271},
  pmid    = {19858456},
  url     = {https://doi.org/10.1212/wnl.0b013e3181bd8271}
}

@article{vandervlies2009-19307538,
  author  = {van der Vlies, A. E. and Verwey, N. A. and Bouwman, F. H. and Blankenstein, M. A. and Klein, M. and Scheltens, P. and van der Flier, W. M.},
  title   = {{CSF biomarkers in relationship to cognitive profiles in Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/01.wnl.0000345014.48839.71},
  pmid    = {19307538},
  url     = {https://doi.org/10.1212/01.wnl.0000345014.48839.71}
}

@article{bos2019-30853464,
  author  = {Bos, I. and Vos, S. and Verhey, F. and Scheltens, P. and Teunissen, C. and Engelborghs, S. and Sleegers, K. and Frisoni, G. and others},
  title   = {{Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2019},
  doi     = {10.1016/j.jalz.2019.01.004},
  pmid    = {30853464},
  url     = {https://doi.org/10.1016/j.jalz.2019.01.004}
}

@article{goos2009-19762705,
  author  = {Goos, J. D. and Kester, M. I. and Barkhof, F. and Klein, M. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.},
  title   = {{Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition}},
  journal = {Stroke},
  year    = {2009},
  doi     = {10.1161/strokeaha.109.558197},
  pmid    = {19762705},
  url     = {https://doi.org/10.1161/strokeaha.109.558197}
}

@article{vermunt2019-31068481,
  author  = {Vermunt, L. and van Paasen, A. J. L. and Teunissen, C. E. and Scheltens, P. and Visser, P. J. and Tijms, B. M. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000007609},
  pmid    = {31068481},
  url     = {https://doi.org/10.1212/wnl.0000000000007609}
}

@article{schoonenboom2004-15136685,
  author  = {Schoonenboom, N. S. and Pijnenburg, Y. A. and Mulder, C. and Rosso, S. M. and Van Elk, E. J. and Van Kamp, G. J. and Van Swieten, J. C. and Scheltens, P.},
  title   = {{Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000123249.58898.e0},
  pmid    = {15136685},
  url     = {https://doi.org/10.1212/01.wnl.0000123249.58898.e0}
}

@article{tolboom2009-19690025,
  author  = {Tolboom, N. and van der Flier, W. M. and Yaqub, M. and Boellaard, R. and Verwey, N. A. and Blankenstein, M. A. and Windhorst, A. D. and Scheltens, P. and others},
  title   = {{Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2009},
  doi     = {10.2967/jnumed.109.064360},
  pmid    = {19690025},
  url     = {https://doi.org/10.2967/jnumed.109.064360}
}

@article{willemse2021-34006321,
  author  = {Willemse, E. A. J. and Scheltens, P. and Teunissen, C. E. and Vijverberg, E. G. B.},
  title   = {{A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00841-4},
  pmid    = {34006321},
  url     = {https://doi.org/10.1186/s13195-021-00841-4}
}